Microglial Activation Syndrome

Research has clearly demonstrated that Inflammation and Excitotoxicity are the driving forces behind Mental Illness and Neurodegeneration. Microglia, the residential immune cells of the CNS, have become the focal point of Mental Health Research due to their crucial role in regulating the neuroinflammatory and excitotoxic cascade, while profoundly impacting Neuroplasticity.

‘Microglial Activation Syndrome’ is the common underlying ‘root cause’ in Mental Illness and Neurodegeneration.

The constituent biomarkers of The Mental M.A.P.™ are the most reliable objective indices that accurately reflect oxidative and neuroinflammatory dysregulation that contribute to microglial activation, neurotransmitter imbalance and concomitant mental health dysfunction.

Core Markers Assessed:

• Homocysteine > assess methylation imbalances.
• KPU > assess oxidative stress and pyrrole disorder.
• MMP-9 > assess blood brain barrier disruption.
• Myeloperoxidase > marker of microglial activation, neuroinflammation and oxidative stress.
• Neopterin > indicates microglial, macrophage and immune activation.

Day 1:

Hour 1-2: The Mental Health Pandemic & an introduction to Microglial Activation Syndrome

Hour 3-4: The Molecular Mechanisms of ‘Microglial Activation Syndrome’ and Neuroplasticity

Hour 5-6: Introduction to The Mental M.A.P.™, biomarker selection and analysis

Day 2:

Hour 1-2: ​Functional Pattern Analysis specific to lab data

Hour 3-4: Designing bioindividualized protocols specific to each molecular target

Hour 5: Integrative intervention strategies for microglial inhibition and neuroplastic promotion

Hour 6: Client case study Live Q&A

Delivery Method